A Study of CC-99677 in Participants With Active Ankylosing Spondylitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

February 21, 2023

Study Completion Date

February 21, 2023

Conditions
Spondylitis, Ankylosing
Interventions
DRUG

CC-99677

Oral

OTHER

Placebo

Oral

Trial Locations (63)

8208

Local Institution - 601, Sabadell

13000

Local Institution - 202, Prague

14001

Local Institution - 606, Córdoba

15006

Local Institution - 604, A Coruña

15706

Local Institution - 602, Santiago de Compostela

16635

Local Institution - 003, Duncansville

22030

Local Institution - 701, Edirne

34098

Local Institution - 705, Istanbul

35100

Local Institution - 706, Izmir

35360

Local Institution - 704, Karabağlar

38119

Local Institution - 002, Memphis

38305

Local Institution - 005, Jackson

41013

Local Institution - 603, Seville

44106

Local Institution - 028, Cleveland

44649

Local Institution - 900, Herne

45417

Local Institution - 004, Dayton

48081

Local Institution - 026, Saint Clair Shores

54100

Local Institution - 702, Adapazarı

58297

Local Institution - 021, Gilbert

61080

Local Institution - 703, Trabzon

61141

Local Institution - 205, Brno

76034

Local Institution - 006, Colleyville

76107

Local Institution - 019, Fort Worth

77099

Local Institution - 008, Houston

78731

Local Institution - 029, Austin

85704

Local Institution - 025, Tucson

86001

Local Institution - 024, Flagstaff

92780

Local Institution - 017, Tustin

95037

Local Institution - 022, Phoenix

97239

Local Institution - 009, Portland

200000

Local Institution - 153, Huangpu District

200040

Local Institution - 154, Shanghai

310014

Local Institution - 152, Hangzhou

430030

Local Institution - 150, Wuhan

500283

Local Institution - 400, Brasov

510630

Local Institution - 151, Guangzhou

702 00

Local Institution - 206, Ostrava

Local Institution - 207, Ostrava

530 02

Local Institution - 201, Pardubice

140 00

Local Institution - 203, Prague

148 00

Local Institution - 211, Prague

686 01

Local Institution - 204, Uherské Hradište

15-077

Local Institution - 311, Bialystok

15-351

Local Institution - 315, Bialystok

85-065

Local Institution - 305, Bydgoszcz

85-168

Local Institution - 302, Bydgoszcz

82-300

Local Institution - 301, Elblag

40-282

Local Institution - 307, Katowice

30-002

Local Institution - 300, Krakow

30-363

Local Institution - 308, Krakow

67-100

Local Institution - 310, Nowa Sól

20-582

Local Institution - 313, Onyksowa 10

96-500

Local Institution - 312, Sochaczew

87-100

Local Institution - 306, Torun

02-691

Local Institution - 303, Warsaw

52-416

Local Institution - 309, Wroclaw

011025

Local Institution - 404, Bucharest

011172

Local Institution - 402, Bucharest

Local Institution - 403, Bucharest

08035

Local Institution - 607, Barcelona

06800

Local Institution - 605, Mérida

06230

Local Institution - 707, Altındağ/Ankara

06100

Local Institution - 700, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY